XtalPi Holdings Limited (HKG:2228)

Market Cap	29.44B +20.9%
Revenue (ttm)	893.17M +201.2%
Net Income	137.71M
EPS	0.03
Shares Out	4.30B
PE Ratio	204.89
Forward PE	291.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,709,620
Open	6.62
Previous Close	6.44
Day's Range	6.49 - 7.01
52-Week Range	5.67 - 15.12
Beta	1.28
Analysts	Strong Buy
Price Target	10.58 (+54.68%)
Earnings Date	Aug 27, 2026

About XtalPi Holdings

XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and drug discovery solutions, such as hit discovery, hit or lead optimizat...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 1,254
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

Financial numbers in CNY

Analyst Summary

According to 7 analysts, the average rating for 2228 stock is "Strong Buy." The 12-month stock price target is $10.58, which is an increase of 54.68% from the latest price.

Price Target

$10.58

(54.68% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error